Main Menu

NASDAQ (usa) arrow 6715.56 -12.11 -0.18%
FTSE 100 (london) arrow 7487.96 -5.12 -0.07%
DAX (german) arrow 13465.51 235.94 1.78%
NIKKEI 225 (japan) arrow 22420.08 408.47 1.86%
Hang - Seng (hong kong) arrow 28594.06 348.52 1.23%
NIFTY - 50 (india)
Straits Times (singapore) arrow 3391.61 17.53 0.52%
KOSPI (korea) arrow 2556.47 33.04 1.31%
All Ordinaries (australia) arrow 6005.30 28.90 0.48%
BOVESPA (brazil) arrow 74092.76 -215.73 -0.29%

Idorsia Ltd (SW: IDIA)

 
IDIA Technical Analysis
3
As on 6th Jun 2025 IDIA STOCK Price closed @ 2.02 and we RECOMMEND Buy for LONG-TERM with Stoploss of 1.89 & Buy for SHORT-TERM with Stoploss of 1.79 we also expect STOCK to react on Following IMPORTANT LEVELS.
 
 

IDIASTOCK Price

Open 2.05 Change Price %
High 2.12 1 Day 0.02 1.00
Low 1.96 1 Week 0.49 32.03
Close 2.02 1 Month 0.86 74.14
Volume 1129242 1 Year -0.11 -5.16
52 Week High 2.86 | 52 Week Low 0.63
 
SW Switzerland Most Active Stocks
CSGN 0.82 0.00%
CSGN 0.82 0.00%
UBSG 27.88 3.80%
UBSG 27.88 3.80%
NESN 86.70 -0.49%
NESN 86.70 -0.49%
NOVN 97.08 0.42%
NOVN 97.08 0.42%
PRFN 0.03 50.00%
ADXN 0.06 0.00%
 
SW Switzerland Top Gainers Stocks
CADN 0.03 50.00%
PRFN 0.03 50.00%
PRFN 0.03 50.00%
BLS 0.13 18.18%
BLS 0.13 18.18%
BLS 0.13 18.18%
NEWN 0.94 17.50%
STLN 1.30 11.11%
CASN 1.90 8.57%
SKIN 32.50 8.33%
 
SW Switzerland Top Losers Stocks
MBTN 0.75 -42.31%
AIRE 0.06 -25.00%
AIRE 0.06 -25.00%
CIE 0.50 -16.67%
CIE 0.50 -16.67%
CIE 0.50 -16.67%
CIE 0.50 -16.67%
CON 98.00 -12.35%
CON 98.00 -12.35%
CON 98.00 -12.35%
 
 
IDIA
Daily Charts		 IDIA
Intraday Charts		 Whats New @
Bazaartrend		 IDIA
Free Analysis
 
IDIA Important Levels Intraday
RESISTANCE2.33
RESISTANCE2.23
RESISTANCE2.17
RESISTANCE2.11
SUPPORT1.93
SUPPORT1.87
SUPPORT1.81
SUPPORT1.71
 
IDIA Forecast June 2025
Share
4th UP Forecast3.99
3rd UP Forecast3.36
2nd UP Forecast2.97
1st UP Forecast2.58
1st DOWN Forecast1.46
2nd DOWN Forecast1.07
3rd DOWN Forecast0.68
4th DOWN Forecast0.05
 
IDIA Weekly Forecast
4th UP Forecast2.79
3rd UP Forecast2.54
2nd UP Forecast2.39
1st UP Forecast2.24
1st DOWN Forecast1.80
2nd DOWN Forecast1.65
3rd DOWN Forecast1.50
4th DOWN Forecast1.25
 
IDIA Forecast2025
4th UP Forecast7.97
3rd UP Forecast6.06
2nd UP Forecast4.88
1st UP Forecast3.7
1st DOWN Forecast0.34
2nd DOWN Forecast-0.84
3rd DOWN Forecast-2.02
4th DOWN Forecast-3.93
 
 
IDIA Other Details
Segment EQ
Market Capital 3191988736.00
Sector Healthcare
Industry Biotechnology
Offical website >
 
IDIA Address
IDIA
 
IDIA Latest News
 
Your Comments and Response on Idorsia Ltd
 
IDIA Business Profile
Idorsia Ltd, a biopharmaceutical company, discovers, develops, and commercializes drugs for unmet medical needs in Switzerland. The company has a clinical development pipeline that cover various therapeutic areas, including CNS, cardiovascular, and immunological disorders, as well as orphan diseases. Idorsia Ltd has a collaboration agreement with Janssen Biotech Inc. to jointly develop and commercialize aprocitentan and its derivative compounds or products; ReveraGen to research and co-develop vamorolone, a non-hormonal steroid modulator for the treatment of duchenne muscular dystrophy; and Hoffman-La Roche Inc. to develop and market compounds in the field of cancer immunotherapy. It also has a collaboration with Antares Pharma, Inc. for the development of a self- administered drug device product for Selatogrel; and Neurocrine Biosciences, Inc. to develop and commercialize ACT-709478, which is in Phase 1 clinical trial for the treatment of epilepsy. The company was incorporated in 2017 and is headquartered in Allschwil, Switzerland. Address: Hegenheimermattweg 91, Allschwil, Switzerland, 4123
 
© 2005-2023 BazaarTrend.com All rights reserved.

Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service